Cargando…

The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs

The intraerythrocytic malaria parasite, Plasmodium falciparum, maintains a low cytosolic Na(+) concentration and the plasma membrane P-type cation translocating ATPase ‘PfATP4’ has been implicated as playing a key role in this process. PfATP4 has been the subject of significant attention in recent y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spillman, Natalie Jane, Kirk, Kiaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559606/ https://www.ncbi.nlm.nih.gov/pubmed/26401486 http://dx.doi.org/10.1016/j.ijpddr.2015.07.001

Ejemplares similares

Na(+) Regulation in the Malaria Parasite Plasmodiumfalciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
por: Spillman, Natalie J., et al.
Publicado: (2013)

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
por: Flannery, Erika L., et al.
Publicado: (2014)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach
por: N., Nagasundaram, et al.
Publicado: (2016)

Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors
por: Tewari, Shivendra G., et al.
Publicado: (2023)

Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012)

Questions over high frequency of mutant PfATP6 haplotypes in traveller isolates
por: Woodrow, Charles J, et al.
Publicado: (2012)

A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4
por: Gilson, Paul R., et al.
Publicado: (2019)

A G358S mutation in the Plasmodium falciparum Na(+) pump PfATP4 confers clinically-relevant resistance to cipargamin
por: Qiu, Deyun, et al.
Publicado: (2022)

PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion
por: Barnes, Claudia B. G., et al.
Publicado: (2022)

Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections
por: Pillai, Dylan R, et al.
Publicado: (2012)

Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium falciparum sarco/endoplasmic reticulum Ca(2+)-ATPase PfATP6
por: Guimarães, Daniel Silqueira Martins, et al.
Publicado: (2015)

Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis
por: Dennis, Adelaide S. M., et al.
Publicado: (2018)

Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
por: Cardi, Delphine, et al.
Publicado: (2010)

Expanding the Antimalarial Drug Arsenal—Now, But How?
por: Grimberg, Brian T., et al.
Publicado: (2011)

Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs
por: Mohring, Franziska, et al.
Publicado: (2022)

The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens
por: Hapuarachchi, Sanduni V., et al.
Publicado: (2017)

Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1‐based vaccines to prevent it
por: Jensen, Anja Ramstedt, et al.
Publicado: (2019)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Goldberg, Daniel E., et al.
Publicado: (2017)

Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type
por: Sa, Juliana M, et al.
Publicado: (2010)

Coordinated action of multiple transporters in the acquisition of essential cationic amino acids by the intracellular parasite Toxoplasma gondii
por: Fairweather, Stephen J., et al.
Publicado: (2021)

The Knockout for G Protein-Coupled Receptor-Like PfSR25 Increases the Susceptibility of Malaria Parasites to the Antimalarials Lumefantrine and Piperaquine but Not to Medicine for Malaria Venture Compounds
por: Santos, Benedito M., et al.
Publicado: (2021)

In Silico Assessment of the Lipid Fingerprint Signature of ATP2, the Essential P4-ATPase of Malaria Parasites
por: López-Martín, Mario, et al.
Publicado: (2022)

The WWARN Antimalarial Quality Surveyor
por: Tabernero, P, et al.
Publicado: (2012)

Effectors of Root-Knot Nematodes: An Arsenal for Successful Parasitism
por: Jagdale, Shounak, et al.
Publicado: (2021)

Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin
por: Chen, Lina, et al.
Publicado: (2021)

PfAlba1: master regulator of translation in the malaria parasite
por: Bunnik, Evelien M., et al.
Publicado: (2015)

The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum
por: Martin, Rowena E, et al.
Publicado: (2005)

ATP2, The essential P4-ATPase of malaria parasites, catalyzes lipid-stimulated ATP hydrolysis in complex with a Cdc50 β-subunit
por: Lamy, Anaïs, et al.
Publicado: (2021)

PfCDPK1 is critical for malaria parasite gametogenesis and mosquito infection
por: Bansal, Abhisheka, et al.
Publicado: (2018)

The Role of the Histone Methyltransferase PfSET10 in Antigenic Variation by Malaria Parasites: a Cautionary Tale
por: Ngwa, Che J., et al.
Publicado: (2021)

Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum
por: Ranford-Cartwright, Lisa C., et al.
Publicado: (2012)

Copper-transporting ATPase is important for malaria parasite fertility
por: Kenthirapalan, Sanketha, et al.
Publicado: (2014)

Studies on the Action of Antimalarial Remedies on Monkey Malaria: The Relationship between the Concentration of Atebrin in the Circulating Blood and Parasite Count
por: Chopra, R. N., et al.
Publicado: (1936)

Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon
por: Brasil, Larissa W, et al.
Publicado: (2012)

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022)

Genetic validation of PfFKBP35 as an antimalarial drug target
por: Thommen, Basil T, et al.
Publicado: (2023)

Structural modifications of quinoline-based antimalarial agents: Recent developments
por: Bawa, Sandhya, et al.
Publicado: (2010)

Human dihydrofolate reductase influences the sensitivity of the malaria parasite Plasmodium falciparum to ketotifen – A cautionary tale in screening transgenic parasites
por: Tran, Phuong N., et al.
Publicado: (2016)

Targeting malaria parasite invasion of red blood cells as an antimalarial strategy
por: Burns, Amy L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rh9tjhsfqhufupa3qe2ufs7kth